Study of a new liquid dressing for moderate-severe uterine scarring
Part of Women’s health & pregnancy clinical trials.
This trial tests a new liquid dressing made from human cells to see if it is safe and helps heal moderate to severe uterine scarring (intrauterine adhesions) in women who want to have children. Participants will receive the dressing during a hysteroscopic procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 20 and 40 years old and want to have children in the future.
- You have been diagnosed with moderate to severe intrauterine adhesions (scarring inside the uterus) confirmed by a camera test called hysteroscopy.
- You are able to have hysteroscopic surgery and your ovaries are working normally (AMH level >= 1.1 ng/mL or antral follicle count >= 5).
- You do not have active pelvic infection, uterine fibroids > 2 cm, or certain other uterine or health problems.
- You have not used high-dose hormone therapy or steroid medications recently, and you are not allergic to hyaluronic acid (a common gel ingredient).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for people with a thin uterine lining or uterine scarring that hasn't responded to other stem cell therapy. It might help improve the lining so pregnancy is possible.
This trial tests a new product designed to prevent scar tissue (adhesions) from forming inside the uterus after surgery. If you have uterine scar tissue causing fertility problems or irregular periods, this study may help determine if the treatment is safe and effective.
This study tests whether infusing a special blood product into the uterus can help heal scar tissue and improve the chances of becoming pregnant. It is for women with moderate to severe uterine adhesions who plan to have surgery to remove the scar tissue.
This trial tests whether infusing special stem cells (from donated bone marrow) into the uterine artery can help thicken the womb lining in women with severe uterine scarring (adhesions) and a history of failed embryo transfers due to thin lining. The goal is to make it possible to successfully implant a frozen embryo and achieve pregnancy.
This study tests a cross-linked hyaluronan gel placed in the uterus to help prevent painful or disruptive scar tissue (adhesions) after a procedure using ultrasound guidance. If you are eligible, the trial may help reduce the chance of future fertility and menstrual problems caused by scar tissue.
This study looks back at medical records to see if a gel called Semical helps prevent scar tissue from forming inside the uterus after surgery. The gel is applied during a hysteroscopy, a procedure to treat conditions like fibroids, polyps, or scar tissue.
Hear when a new Moderate-Severe Intrauterine Adhesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.